José M. de Miguel‐Yanes

Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms

José M. de Miguel‐Yanes, Peter Shrader, Michael Pencina et al. · Diabetes Care · 2010 · 175 citations · Full text

Life Sciences, Biostatistics, Genetics +17

Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study) : results from the MADIABETES cohort

Miguel Á. Salinero-Fort, Paloma Gómez‐Campelo, F. Javier San Andrés-Rebollo et al. · BMJ Open · 2018 · 103 citations · Full text

Medicine, Endocrinology, Psychiatry +17

Failure to implement evidence-based clinical guidelines for sepsis at the ED

José M. de Miguel‐Yanes, Juan A. Andueza-Lillo, Víctor José González Ramallo et al. · The American Journal of Emergency Medicine · 2006 · 91 citations

Veterinary Medicine, Emergency Medicine, Clinical Decision Support +11

Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features

Ana Bustamante‐Fermosel, José M. de Miguel‐Yanes, Mercedes Duffort‐Falcó et al. · The American Journal of Emergency Medicine · 2007 · 85 citations

Medicine, Clinical Sciences, Internal Medicine +6

Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study

Víctor Cornejo Del Río, José María Mostaza, Carlos Lahoz et al. · PLoS ONE · 2017 · 62 citations · Full text

Medicine, Endocrinology, Diabetology +13